TG Therapeutics (TGTX) Shares Move Up from Lows Amid Amended GENUINE Phase 3 Protocol

October 13, 2016 7:24 AM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

TG Therapeutics (Nasdaq: TGTX) shares are seeing a slight rebound Thursday morning after the company announced an amended protocol for its GENUINE Phase 3 trial. The stock is down around 4 percent, but was 22 percent lower Wednesday night.

For more on the updated protocol, click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Momentum Movers, Trader Talk

Add Your Comment